Head of Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute
I am a scientist at the Wellcome Sanger Institute who is interested in mutations in cancer and normal cells.
My research programme focuses on the genetic changes our cells acquire as we go through life, and how these mutations are related to ageing, cancer and other disease processes.
My major interest is in cancer genomics, and in particular genome-wide analyses of somatic mutations in tumours, as well as: the discovery of new cancer genes; the identification of somatic mutation processes operative in tumours; the characterisation of patterns of cancer evolution; and the translation of these fundamental insights about cancer biology into better management of patients. I am increasingly interested in the role of somatic mutations outside of cancer. Particular focus areas include how somatic mutations delineate clonal relationships of normal cellular populations and how somatic mutations affect normal cellular behaviour.
Lung cancer: quitting smoking regrows protective lung cells – new research
Feb 03, 2020 12:27 pm UTC| Health
We know that quitting smoking is an excellent way to reduce your risk of developing lung cancer. But until now, experts werent quite sure why this was the case. Our latest research has uncovered that in people who quit...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight